Find Press / Media

Search results

• A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302)

  Jong Hak Kim, Hyunsoo Kim & JaeHee Cheon

  18/10/2

  1 item of Media coverage

  Press/Media: Press / Media

• A Phase III Trial of Carboplatin as Adjuvant Chemotherapy in Triple Negative Breast Cancer

  Byeongwoo Park

  18/10/2

  1 item of Media coverage

  Press/Media: Press / Media

• A Phase II Study of M2951 in Systemic Lupus Erythematosus (SLE)

  Jong-Seok Lee, YongBeom Park & Jongeun Lee

  18/10/2

  1 item of Media coverage

  Press/Media: Press / Media

• A picture perfect power source

  Sang-Young Lee

  16/8/4

  2 items of Media coverage

  Press/Media: Press / Media

• A Pilot Study Exploring the Efficacy and Safety of Herbal Medicine on Korean Obese Women With Metabolic Syndrome Risk Factors - Double Blinded, Randomized, Multicenter, Placebo Controlled Clinical Trial -

  Hyun Woo Park

  18/10/2

  1 item of Media coverage

  Press/Media: Press / Media

• Apollo Hospitals announces Q2FY17 results

  Yoonwoo Koh

  16/11/11

  1 item of Media coverage

  Press/Media: Press / Media

• A possible blood test for early-stage Alzheimer's disease

  YoungSoo Kim

  19/4/18

  1 item of Media coverage

  Press/Media: Press / Media

• A powerful catalyst for electrolysis of water that could help harness renewable energy

  Seong-Ju Hwang

  19/1/25

  2 items of Media coverage

  Press/Media: Press / Media

• Apple Fixes “chaiOS” Text Bomb Bug Along with Several Other Security Issues with iOS 11.2.5

  Taekyoung Kwon

  18/1/23

  1 item of Media coverage

  Press/Media: Press / Media

• Apple iOS/tvOS/MacOS/watchOS Multiple Security Vulnerabilities

  Taekyoung Kwon

  16/9/20

  1 item of Media coverage

  Press/Media: Press / Media

• Apple jack ax ushers in a voice-driven world

  Young-Wook Lee

  16/9/7

  1 item of Media coverage

  Press/Media: Press / Media

• Apple macOS/OS X Multiple Flaws Let Remote and Local Users Deny Service, Obtain Potentially Sensitive Information, Execute Arbitrary Code, and Gain Elevated Privileges

  Taekyoung Kwon

  16/9/21

  1 item of Media coverage

  Press/Media: Press / Media

• Apple Releases Important iOS 11.2.5 Update: What Features Are Included?

  Taekyoung Kwon

  18/1/23

  1 item of Media coverage

  Press/Media: Press / Media

• Apple releases watchOS 4.2.2

  Taekyoung Kwon

  18/1/23

  2 items of Media coverage

  Press/Media: Press / Media

• Apple Security Advisory 2016-09-20-3

  Taekyoung Kwon

  16/9/20

  1 item of Media coverage

  Press/Media: Press / Media

• Apple Security Advisory 2016-09-20-6

  Taekyoung Kwon

  16/9/20

  1 item of Media coverage

  Press/Media: Press / Media

• Apple Security Advisory 2018-1-23-1

  Taekyoung Kwon

  18/1/24

  1 item of Media coverage

  Press/Media: Press / Media

• Apple Security Advisory 2018-1-23-2

  Taekyoung Kwon

  18/1/24

  1 item of Media coverage

  Press/Media: Press / Media

• Apple Security Advisory 2018-1-23-3

  Taekyoung Kwon

  18/1/25

  1 item of Media coverage

  Press/Media: Press / Media

• Apple Security Advisory 2018-1-23-4

  Taekyoung Kwon

  18/1/25

  1 item of Media coverage

  Press/Media: Press / Media

• Application of CRISPR/Cas9-based mutant enrichment technique to improve the clinical sensitivity of plasma EGFR testing in patients with non-small cell lung cancer

  Taewha Lee

  22/2/15

  1 item of Media coverage

  Press/Media: Press / Media

• Applied Materials Today welcomes Prof Martin Pumera

  Martin Pumera

  16/7/5

  1 item of Media coverage

  Press/Media: Press / Media

• Apr 29, 2019, 4:55 am PDT Women did everything right. Then work got ‘greedy.’

  Youngjoo Cha

  19/4/29

  1 item of Media coverage

  Press/Media: Press / Media

• A Prospective Comparison of Robotic and Endoscopic SMG Resection Via Retroauricular Approach

  Yoonwoo Koh

  18/10/2

  1 item of Media coverage

  Press/Media: Press / Media

• A Randomized, Double-blind, Active Control, Parallel Group, Titration, Multicenter Study to Evaluate the Efficacy and Safety of Fimasartan

  Sungha Park

  18/10/2

  1 item of Media coverage

  Press/Media: Press / Media